Advances in Cancer Immunotherapy™: A Focus on Gastrointestinal Cancers

When:  Dec 4, 2023 from 13:00 to 17:00 (ET)
This program will be hosted virtually.


Paige Griffith, MSN, AG-ACNP, BSN - Johns Hopkins University
Suwicha Limvorasak, PharmD - Cedars Sinai Medical Center
Arsen Osipov, MD - Cedars Sinai Medical Center
Mark Yarchoan, MD - Johns Hopkins Medicine

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:

  • Identify the cancer immunotherapy approaches in use for the treatment of gastrointestinal cancers.
  • Summarize recent updates in cancer immunotherapy for gastrointestinal cancers including emerging toxicities and management.
  • Implement cancer immunotherapy for gastrointestinal cancer into clinical practice appropriately.
Attendees will also have an opportunity for connecting with experts in the immunotherapy field at the virtual event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.

For more information on the program, click below.


View the SITC Meeting Code of Conduct.